Paediatric Care Clinic
TRUSTED CARE FOR CHILDREN OF ALL BACKGROUNDS
From Disadvantaged to Professional Families
Care, Compassion, Communication and Quality

Translating Latest Research Update to Clinical Practice


The review included a pooled total of 2,110 participants. The majority of studies involved participants aged 5–12 years. More males were included than females; ten
studies included only males. Outcomes were measured in a variety of classroom settings: 15 studies were set in a conventional academic classroom,
15 in analogue or laboratory classrooms and 12 in classrooms that were part of Summer Treatment Programs.



Meta-analysis of Efficacy of Different Stimulants in Children with ADHD























Before stimulant treatment introduction (Sweden), the odd ratios was 1.3 for “below‑average height” among ADHD vs non‑ADHD (Meaning those with ADHD had ~31% higher odds of below‑average height even when medications weren’t yet used.)
After stimulant treatment became available, the same odd of 1.21 for “below‑average height” among ADHD vs non‑ADHD, meaning a similar magnitude, only slightly less strong, which suggests that medication availability didn’t dramatically change the association.
In family‐based designs (siblings, half‑siblings, cousins), relatives of those with ADHD (but who themselves don’t have diagnosed ADHD) also have increased odds of shorter height, though weaker than the ADHD vs non‑ADHD direct comparison. For example, full siblings have Odd Ratio ~1.14. This suggests familial liability (shared genetic factors and/or shared environment) plays a meaningful role.





